News and Comments

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

ZALTRAP™ Revlimid (lenolidamide) Intermune (ITMN) ARGOS (ARGS) Ariad (ARIA) GUARDIAN HEALTH Rapamune Incyte (INCY) INNOVIVA (INVA) Sarepta (SRPT) Inovio (INO) CompuGen (CGEN) Elan (ELN) ACADIA (ACAD) NANTKWEST (NK) Human Longevity (HLI) Abbott Laboratories (ABT) AERIE PHARMACEUTICALS Editas (EDIT) Roche (ROCHE) Idenix (IDIX) Ziofpharm (ZIOP) KITE (KITE) Valeant Pharmaceuticals International (VRX) ISIS (ISIS) Anacor (ANAC) Agenus (AGEN Prolor Biotech (PBTH) Amgen (AMGN) NEKTAR (NKTR)) Mirati Therapeutics (MRTX) Intrexon (XON) HALOZYME (HALO) Benlysta (belimumab) Multiple Myeloma Vertex (VRTX) Telaprevir galapagos (GLPG) Herceptin Exelixis (EXEL) RenenxBio (RGNX) Anadys (ANDS) Theravance (THRX) Ridaforolimus Pluristem (PSTI) Bristol-Myers Squibb (BMY) Global Cell Therapeutics (GBT) Cytokinetics (CYTK) REGULUS (RGLS) Onyx (ONXX) GlaxoSmithKline (GSK) ADVENTRIX (ANX) Tysabri C4 Therapeutics Alnylam (ALNY) Sanofi (SNY) Micromet (MITI) Ionis (IONS) Sequenom (SQNM) Illumina (ILMN) Sanofi-Aventis (SAN) Gilead (GILD) Velcade (bortezomib) Aimmune Therapeutics (AIMT) IDERA (IDRA) Biocryst (BCRX) Regeneron (REGN) Galena (GALE) ARCA (ABIO) Theravance Bio Pharma (TBPH) Spike Therapeutics (ONCE) Dynavax (DVAX) AGOS (ARGS) Biogen Idec (BIIB) JUNO (JUNO) Seattle Genetics (SGEN) Trastuzumab-DM1 Endometrial Cancer TOKAI (TKAOI) Xoma (XOMA) SERES THERAPEUTICS (MCRB) SYNTA (SNTA) VANDA (VNDA) BIOMARIN (BMRN) Jazz Pharmaceuticals (JAZZ) Dendreon (DNDN) Array Pharmaceuticals (ARRY) Sangamo (SGMO) Human Genome Sciences (HGSI) Sanofi (SNA) KERYX (KERX) Alder Biopharmaceuticals (ALDR) PTC Therapeutics (PTCT) ImmunoGen (IMGN) Genentech ABBVIE (ABBV) Roche (RHHBY) Agenus (AGEN) Zerenex Auspex (ASPX) SUNESIS PHARMACEUTICALS (SNSS) OSI (OSIP) Merck (MRK) Vitae Pharmaceuticals (VTAE) Prosensa (RNA) Intercept (ICPT)